# GLP-1 Seller Disclosure Gaps: Dose Pricing, State Coverage, Formats | This GLP How many GLP-1 sellers leave dose pricing, state coverage and catalog breadth unpublished, counted across several hundred sellers, and three questions to ask one before ordering. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/research/what-glp1-sellers-do-not-publish Updated: 2026-10-28 Published: 2026-09-15 [← Research](https://thisglp.com/research) Formats # GLP-1 Seller Disclosure Gaps: Dose Pricing, State Coverage, Formats Across several hundred GLP-1 sellers, a count of how many publish nothing about dose pricing, nothing about state coverage and nothing beyond a single format, and why silence is not the same as concealment. [This GLP Editorial Team](https://thisglp.com/about)September 20265 min readUpdated September 2026 Says nothing about dose · 370 · No coverage list · 379 · One format only · 467 **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms). ## Key takeaways - 370 of 580 sellers on this roster — 64% — publish nothing about what their price does at a higher dose. - 379 record no list of states they ship to. - 467 offer one format only, and 105 one molecule. - Every count here is 'published nothing on this point'. None of them is a finding that a seller is concealing anything. - Corpus: 580 sellers, read most recently October 2026. Most of what decides whether a GLP-1 service suits a particular reader is not on its pricing page. That is not a scandal — it is a pattern, and it is consistent enough across several hundred sellers to count rather than assert. ## The four common silences **What happens at a higher dose.** 370 sellers of 580 publish nothing either way. 166 state the rate holds and 44 state it rises. Since almost everyone escalates inside the first sixteen weeks, this is the silence that costs the most — and [the sellers that do publish a ladder](https://thisglp.com/tools/published-dose-ladders) are a small minority of the roster. **Where they can ship.** 379 sellers record no state list at all. A reader in a licensing-thin state cannot tell from the page whether the service is available to them, and a price that cannot be bought is not a price. [Coverage by state](https://thisglp.com/tools/coverage-by-state) shows how unevenly that falls. **What else they sell.** 467 offer a single format, so a reader who wants a tablet rather than an injection is choosing from a much smaller field than the headline count suggests. 105 carry a single molecule, which [the molecule and format finder](https://thisglp.com/tools/molecule-and-format-finder) breaks down seller by seller. An unfilled field is not a refusal A seller counted in any of these groups has not been shown to be withholding anything. It has been shown not to have written the sentence down on a page this desk has read. Most will answer the question in a message; the point of counting is that the answer is worth having in writing before money changes hands, and that the industry norm is to leave it unwritten. ## What to send before ordering One message covers most of it: _does this figure change as my dose goes up, and if so what does it become; can you ship to my state; and is there any charge outside the figure on the page?_ A seller that answers all three in writing has done more than most of this market does in public. [The open-questions tool](https://thisglp.com/tools/questions-they-leave-open) keeps the current counts, and [the scorecard](https://thisglp.com/tools/what-sellers-publish) shows how each ranked seller does on the five things this site marks. Counts are computed from this site’s own records at build time, most recently read October 2026. Nothing is modeled or taken from a third party. One useful disclosure is who actually provides the care. [Embody](https://thisglp.com/reviews/embody) distinguishes its platform from independent medical groups in its [terms](https://joinem.co/pages/terms-conditions). A storefront name alone therefore does not identify the prescriber. Ask which practice will hold your records and handle a problem after dispensing. ## Frequently asked Does a missing answer mean a seller is hiding something? No. Every count here means 'published nothing on this point' on the pages this desk has read. Most sellers will answer in a message; the finding is that the norm is to leave it unwritten. Which silence matters most? What the price does at a higher dose. Almost everyone escalates inside sixteen weeks, so an opening figure with no stated dose behavior describes the cheapest month of a course. Where do these counts come from? This site's own seller records, computed when the page was built. No third-party dataset is involved. ## Sources ## Where to get it ### Best GLP-1 injections Every injectable seller we can verify, with the price each one publishes and an honest read of what the trials measured. [Compare providers →](https://thisglp.com/best/compounded-semaglutide) ## More in Formats - [ Label-approved sites and semaglutide exposure · Abdomen · 2 in. from navel · similar · Thigh · under the skin · similar · Upper arm · under the skin · similar · Blood levels, not weight loss. No trial randomized people to a site. ### Where Should You Inject Ozempic? Abdomen, Thigh or Arm Gave the Same Exposure ](https://thisglp.com/research/where-should-you-inject-ozempic) - [ The labeled ladder — four weeks on every rung · 0.25 · wk 1–4 · 0.5 · wk 5–8 · 1 · wk 9–12 · 1.7 · wk 13–16 · 2.4 · wk 17+ · Milligrams weekly. No compounded product carries this label. ### Semaglutide Starting Dose: 0.25 mg, and What Compounding Changes ](https://thisglp.com/research/semaglutide-starting-dose) - [ Approved: weight management, US, April 2026 · Phase 3 in progress, not approved: · sleep apnea · hypertension · urinary incontinence · osteoarthritis pain · artery disease · A daily tablet, not a peptide, not an injection. ### Is There a GLP-1 Pill That Works? Two Tablets, Two Different Answers ](https://thisglp.com/research/does-the-glp1-pill-work-as-well-as-the-injection)